MedPath

Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Completed
Conditions
Depressed Lateral Condyle Fracture
Benign Bone Tumour Cavity
Spinal Fusion
Registration Number
NCT00935870
Lead Sponsor
Vivoxid Ltd
Brief Summary

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Written informed consent obtained; Participation of previous clinical investigation with bioactive glass
Exclusion Criteria
  • The subject is unlikely to adhere to study procedures
  • Concurrent disease or condition that in the opinion of the investigator is contraindicating participation
  • Simultaneous participation in another medical device or investigational drug trial

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Turku University Hospital

🇫🇮

Turku, Finland

Turku University Hospital
🇫🇮Turku, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.